Patanjali slams USFDA report on differential labelling by Patanjali Ayurveda

  • 5 years ago
Baba Ramdev's Patanjali Ayurveda has slammed the US health regulator USFDA for its report raising concerns about differential labelling by Patanjali Ayurveda. In a report, USFDA had claimed that labels on two Patanjali products sold in India were found to have additional medicinal & dietary claims compared to the products manufactured for exports.

Recommended